Assignee profile:

OmniGen Research, L.L.C.

City:

Corvallis, Oregon

Country:

United States

Published Applications:

25

Last publication date:

2023-08-03

Patent Grants:

15

Last grant date:

2025-11-04

Top Inventors for applications by OmniGen Research, L.L.C.

These are the the leading inventors for applications assigned to OmniGen Research, L.L.C.:

Recent patent applications by OmniGen Research, L.L.C.

OmniGen Research, L.L.C. based in Corvallis, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-08-03 ✅ Patent 12,458,043 granted on 2025-11-04
US20230240326A1
Human necessities

BACILLUS COMBINATION FOR ADMINISTRATION TO ANIMALS

#2 | 2021-12-02 ✅ Patent 11,627,749 granted on 2023-04-18
US20210368827A1
Human necessities

Composition and/or combination for aquaculture

#3 | 2021-10-28
US20210330752A1
Human necessities

FEED SUPPLEMENTS

#4 | 2020-11-19 ✅ Patent 11,653,674 granted on 2023-05-23
US20200359653A1
Human necessities

combination for administration to animals

#5 | 2020-05-07 ✅ Patent 11,419,888 granted on 2022-08-23
US20200138850A1
Human necessities

Composition and method for promoting reduction of heat stress in animals

#6 | 2020-03-26
US20200093158A1
Human necessities

COMPOSITIONS AND COMBINATIONS FOR USE AS FOOD SUPPLEMENTS FOR ANIMALS

#7 | 2019-12-12
US20190374622A1
Human necessities

COMPOSITION AND METHOD FOR CO-ADMINISTRATION WITH A GROWTH PROMOTANT

#8 | 2018-07-26
US20180206528A1
Human necessities

GRANULATED FEED SUPPLEMENT AND METHODS FOR MAKING AND USING

#9 | 2018-07-12
US20180192670A1
Human necessities

COMPOSITION AND/OR COMBINATION FOR AQUACULTURE

#10 | 2018-05-17
US20180133242A1
Human necessities

COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS

#11 | 2018-01-25
US20180021366A1
Human necessities

COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS

#12 | 2017-07-20
US20170202244A1
Human necessities

COMPOSITIONS AND COMBINATIONS FOR USE AS FOOD SUPPLEMENTS FOR ANIMALS

#13 | 2016-12-01 ✅ Patent 10,555,964 granted on 2020-02-11
US20160346314A1
Human necessities

Composition and method for promoting reduction of heat stress in animals

#14 | 2016-05-12
US20160129092A1
Human necessities

USE OF BETA-1,3 (4)-ENDOGLUCANOHYDROLASE, BETA-1,3 (4)-GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION

#15 | 2015-12-31
US20150374740A1
Human necessities

COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS

#16 | 2015-01-22 ✅ Patent 9,114,129 granted on 2015-08-25
US20150024005A1
Human necessities

Augmentation of titer for vaccination in animals

#17 | 2014-05-08 ✅ Patent 8,828,402 granted on 2014-09-09
US20140127263A1
Human necessities

Augmentation of titer for vaccination in animals

#18 | 2014-04-24 ✅ Patent 9,173,926 granted on 2015-11-03
US20140112907A1
Human necessities

Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function

#19 | 2014-01-23 ✅ Patent 8,834,868 granted on 2014-09-16
US20140023633A1
Human necessities

Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function

#20 | 2013-09-12 ✅ Patent 8,663,644 granted on 2014-03-04
US20130236482A1
Human necessities

Augmentation of titer for vaccination in animals

#21 | 2013-01-17 ✅ Patent 8,568,715 granted on 2013-10-29
US20130017211A1
Human necessities

Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function

#22 | 2012-06-21 ✅ Patent 8,431,133 granted on 2013-04-30
US20120156248A1
Human necessities

Augmentation of titer for vaccination in animals

#23 | 2007-11-01 ✅ Patent 8,142,798 granted on 2012-03-27
US20070253983A1
Human necessities

Augmentation of titer for vaccination in animals

#24 | 2007-08-30 ✅ Patent 8,236,303 granted on 2012-08-07
US20070202092A1
Human necessities

Use of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function

#25 | 2006-10-26 ✅ Patent 7,939,066 granted on 2011-05-10
US20060239992A1
Human necessities

Methods and compositions for the inhibition of growth of infectious and other mycotic organisms in the gut of mammalian and avian species

Also check out OmniGen Research, L.L.C.'s (Corvallis, United States) applicant profile with 10 patent applications submitted.

AssigneeID:

38512 ⎘